ANGO - AngioDynamics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

AngioDynamics, Inc.

14 Plaza Drive
Latham, NY 12110
United States
518-795-1400
http://www.angiodynamics.com

Sector : Healthcare
Industry : Medical Instruments & Supplies
Full Time Employees :

Key Executives

Name Title Pay Exercised Year Born
Mr. James C. Clemmer CEO, Pres & Director 957.51k N/A 1964
Mr. Michael C. Greiner Exec. VP & CFO 542.59k N/A 1973
Mr. David D. Helsel Sr. VP of Global Operations and R&D 280.41k N/A 1964
Mr. Stephen A. Trowbridge Sr. VP & Gen. Counsel 419.27k N/A 1974
Mr. Robert A. Simpson Sr. VP & GM of Vascular Interventions and Therapies 516.57k N/A 1972
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. It also offers thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. In addition, the company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; and Asclera injection for treating uncomplicated spider and reticular veins of the lower extremities. Further, it provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation system; and radiofrequency ablation products for ablating solid cancerous or benign tumors. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

Corporate Governance

AngioDynamics, Inc.’s ISS Governance QualityScore as of June 25, 2019 is 3. The pillar scores are Audit: 3; Board: 3; Shareholder Rights: 5; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) . Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.